These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease. Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669 [TBL] [Abstract][Full Text] [Related]
9. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer. Peel E; Belov K Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648 [TBL] [Abstract][Full Text] [Related]
10. Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells. Ong CEB; Lyons AB; Woods GM; Flies AS Front Immunol; 2018; 9():3117. PubMed ID: 30692995 [TBL] [Abstract][Full Text] [Related]
11. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils. Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814 [TBL] [Abstract][Full Text] [Related]
12. Natural killer cell mediated cytotoxic responses in the Tasmanian devil. Brown GK; Kreiss A; Lyons AB; Woods GM PLoS One; 2011; 6(9):e24475. PubMed ID: 21957452 [TBL] [Abstract][Full Text] [Related]
13. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii). Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil. Patchett AL; Latham R; Brettingham-Moore KH; Tovar C; Lyons AB; Woods GM Dev Comp Immunol; 2015 Nov; 53(1):123-33. PubMed ID: 26182986 [TBL] [Abstract][Full Text] [Related]
15. Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils. Peck S; Corkrey R; Hamede R; Jones M; Canfield P Vet Clin Pathol; 2016 Sep; 45(3):417-29. PubMed ID: 27589840 [TBL] [Abstract][Full Text] [Related]
16. Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Siddle HV; Kreiss A; Tovar C; Yuen CK; Cheng Y; Belov K; Swift K; Pearse AM; Hamede R; Jones ME; Skjødt K; Woods GM; Kaufman J Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5103-8. PubMed ID: 23479617 [TBL] [Abstract][Full Text] [Related]
17. Complex associations between cancer progression and immune gene expression reveals early influence of transmissible cancer on Tasmanian devils. Raven N; Klaassen M; Madsen T; Jones M; Hamilton DG; Ruiz-Aravena M; Thomas F; Hamede RK; Ujvari B Front Immunol; 2024; 15():1286352. PubMed ID: 38515744 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials. Patchett AL; Tovar C; Blackburn NB; Woods GM; Lyons AB Immunol Cell Biol; 2021 Aug; 99(7):711-723. PubMed ID: 33667023 [TBL] [Abstract][Full Text] [Related]
19. MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer. Siddle HV; Marzec J; Cheng Y; Jones M; Belov K Proc Biol Sci; 2010 Jul; 277(1690):2001-6. PubMed ID: 20219742 [TBL] [Abstract][Full Text] [Related]
20. The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines. Patchett AL; Darby JM; Tovar C; Lyons AB; Woods GM PLoS One; 2016; 11(12):e0168068. PubMed ID: 27936237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]